Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AptaTargets initiates first-in-human trial of ApTOLL

July 1, 2019

FDA approves Soliris for neuromyelitis optica spectrum disorder

June 28, 2019

Sage Therapeutics identifies GABA-A receptor modulators

June 28, 2019

Wave Life Sciences initiates DYSTANCE 51 phase II/III study of suvodirsen

June 28, 2019

Ovid Therapeutics initiates phase III NEPTUNE trial

June 28, 2019

Esteve Pharmaceuticals describes new analgesics

June 27, 2019

Bionomics reports results from phase II exploratory study of BNC-210

June 27, 2019

New lactam derivatives acting as H3 receptor ligands with potential for the treatment of pain

June 26, 2019

Study gives insights into Parkinson's beyond dopamine

June 26, 2019

Bionomics patents nicotinic alpha7 receptor negative allosteric modulators

June 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...